Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by Bigcity1on Dec 05, 2016 4:11pm

61 Views

Post# 25556735

RE:RE:RE:Tooooooooooomany shares outstanding

Yes it is 73 Million as per the website From the news release "VANCOUVER, British Columbia, Dec. 05, 2016 (GLOBE NEWSWIRE) -- New Age Farm Inc. (CSE:NF) (OTC:NWGFF) (FSE:ONF) (www.newagefarminc.com) (New Age Farm or the Company), is pleased to provide this update regarding the plan of arrangement (the Arrangement) between New Age Farm and NHS Industries Ltd (NHS). As previously reported on November 10, 2016, the shareholders of the Company have approved the Arrangement and the Company has set the share distribution record date at November 30, 2016 (the Share Distribution Record Date). As of the Share Distribution Record Date, New Age Farm has 105,573,317common shares issued and outstanding."

Bullboard Posts

Unique Battery Metals opportunity in Quebec